Abstract
One of the first applications of peptide arrays in general and those prepared by SPOT synthesis in particular was the mapping of antibody epitopes. In this article the diverse applications in this field are described. Different types of peptide libraries such as peptide scans, substitution analyses, truncation and deletion libraries as well as combinatorial and randomly generated libraries are briefly covered. Furthermore, their applications for antibody epitope mapping are described. These are: (i) identification of antigenic determinants within protein sequences for monoclonal and polyclonal antibodies, (ii) identification of key residues for binding, mapping of linear and discontinuous binding sites, (iii) paratope mapping, (iv) identification of mimotopes, and finally (v) the profiling of complex (auto)antibody signatures in biological fluids such as human or mice sera to identify novel biomarkers for e.g. cancer, allergy, infectious and autoimmune diseases.
Keywords: Antibody, antigen, diagnostics, epitope mapping, peptide library, peptide microarray, peptide scan, SPOT synthesis
Mini-Reviews in Organic Chemistry
Title: Peptide Arrays for the Analysis of Antibody Epitope Recognition Patterns
Volume: 8 Issue: 2
Author(s): Ulf Reimer, Ulrich Reineke and Mike Schutkowski
Affiliation:
Keywords: Antibody, antigen, diagnostics, epitope mapping, peptide library, peptide microarray, peptide scan, SPOT synthesis
Abstract: One of the first applications of peptide arrays in general and those prepared by SPOT synthesis in particular was the mapping of antibody epitopes. In this article the diverse applications in this field are described. Different types of peptide libraries such as peptide scans, substitution analyses, truncation and deletion libraries as well as combinatorial and randomly generated libraries are briefly covered. Furthermore, their applications for antibody epitope mapping are described. These are: (i) identification of antigenic determinants within protein sequences for monoclonal and polyclonal antibodies, (ii) identification of key residues for binding, mapping of linear and discontinuous binding sites, (iii) paratope mapping, (iv) identification of mimotopes, and finally (v) the profiling of complex (auto)antibody signatures in biological fluids such as human or mice sera to identify novel biomarkers for e.g. cancer, allergy, infectious and autoimmune diseases.
Export Options
About this article
Cite this article as:
Reimer Ulf, Reineke Ulrich and Schutkowski Mike, Peptide Arrays for the Analysis of Antibody Epitope Recognition Patterns, Mini-Reviews in Organic Chemistry 2011; 8 (2) . https://dx.doi.org/10.2174/157019311795177835
DOI https://dx.doi.org/10.2174/157019311795177835 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Use of Synbiotics for Ulcerative Colitis Treatment
Current Clinical Pharmacology Natural Killer T Cells and Autoimmune Disease
Current Molecular Medicine The Role of HLA Promoters in Autoimmunity
Current Pharmaceutical Design Involvement of Membrane Channels in Autoimmune Disorders
Current Pharmaceutical Design Immune Monitoring to Predict the Development of Infections After Immunosuppression for Solid Organ Transplantation and Autoimmune Diseases
Current Drug Safety Patients’ Induced Pluripotent Stem Cells to Model Drug Induced Adverse Events: A Role in Predicting Thiopurine Induced Pancreatitis?
Current Drug Metabolism HLA-G and Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Biological Activities, Mechanisms of Action and Biomedical Prospect of the Antitumor Ether Phospholipid ET-18-OCH3 (Edelfosine), A Proapoptotic Agent in Tumor Cells
Current Drug Metabolism Therapeutic Targeting of CD6 in Autoimmune Diseases: A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab
Current Drug Targets Macrophage Migration Inhibitory Factor - A Favorable Marker in Inflammatory Diseases?
Current Medicinal Chemistry Update on Pathogenesis of Sjogren's Syndrome
Current Rheumatology Reviews Pharmacological Targeting of IDO-Mediated Tolerance for Treating Autoimmune Disease
Current Drug Metabolism Therapeutic Potential of Natural Products from Terrestrial Plants as TNF-α Antagonist
Current Topics in Medicinal Chemistry Are B Cells a Potential Target for Therapeutic Intervention in the Classical T Cell-Mediated Autoimmune Disease Type 1 Diabetes?
Inflammation & Allergy - Drug Targets (Discontinued) Current and Potential Agents for the Treatment of Alopecia Areata
Current Pharmaceutical Design Use of Mesenchymal Stem Cells in Crohn's Disease and Perianal Fistulas: A Narrative Review
Current Stem Cell Research & Therapy Vaccination and Induction of Autoimmune Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Cytokine Therapies in Crohns Disease: Where are We Now and where should We Go?
Inflammation & Allergy - Drug Targets (Discontinued) The Unique Inhibitory IgG Receptor--FcγRIIb
Protein & Peptide Letters New Insights on the Possible Role of Mast Cells in Aspirin-Induced Asthma
Current Molecular Pharmacology